
Though patients had a clinically meaningful increase in pre-bronchodilator FEV1, they did not evidence a significantly improved annualized asthma exacerbation rates compared with placebo.

Though patients had a clinically meaningful increase in pre-bronchodilator FEV1, they did not evidence a significantly improved annualized asthma exacerbation rates compared with placebo.

The specifics of the "minor deficiencies" cited by the FDA will be relayed on June 27, 2018, upon the official issuance of the CRL.

The CDC reports that of the 2 million people who get an infection from antibiotic-resistant bacteria each year, about 23,000 die.

Children with autism are nearly twice as likely to have any allergic condition than those without autism, researchers found.

Between 60-80% of pediatric asthma exacerbations are triggered by respiratory pathogens. For most children, the common cold is the culprit.



















A trial of 2 different vitamin D supplementation methods found that one of them is capable of reducing recurrent wheezing in preterm infants.

The fluticasone propionate nasal spray is indicated for treatment of seasonal and perennial allergic rhinitis, as well as the management of sinus pain and pressure associated with pediatric rhinitis.